Skip to main content
. Author manuscript; available in PMC: 2012 Apr 23.
Published in final edited form as: Vaccine. 2011 Mar 9;29(18):3431–3437. doi: 10.1016/j.vaccine.2011.02.071

Table 3. Demographic, atopy, and exposures study characteristics for cases of laboratory confirmed influenza and controls.

Cases with influenza infection (n=8) Controls with no influenza infection (n=73) p-valuea
Mean age – mo. 25.3 23.2 0.43
Sex – no. (%)
    Male
    Female

4 (50%)
4 (50%)

41 (54.7%)
34 (45.3%)
1.00
Race – no. (%)
    European-American
    African-American
    Mixed

8 (100%)
0
0

69 (94.5%)
2 (2.7%)
2 (2.7%)
1.00
Season bornb - no. (%)
    Spring
    Summer
    Fall
    Winter

4 (50.0%)
2 (25.0%)
1 (12.5%)
1 (12.5%)

23 (31.5%)
19 (26.0%)
15 (20.6%)
16 (21.9%)
0.82
No. of children in home – no. (%)
    One
    Two
    ≥Three

1 (12.5%)
3 (37.5%)
4 (50.0%)

4 (5.6%)
31 (43.7%)
36 (50.7%)
0.58
Born premature (<36 wks) – no. (%) 0 9 (12.5%) 0.59
Breastfeed – no. (%) 8 (100%) 53 (72.6%) 0.19
Live in home with pet(s)a – no. (%) 4 (57.1%) 32 (60.4%) 1.00
Live in home with smoker(s) – no. (%) 2 (25.0%) 4 (5.6%) 0.11
Patient or sibling attends daycare – no. (%) 6 (75.0%) 62 (82.7%) 0.63
Personal history of asthma/wheezing – no. (%) 3 (37.5%) 30 (40.5%) 1.00
Personal history of atopy – no. (%) 4 (50.0%) 20 (27.4%) 0.29
Maternal history of asthma/wheezing – no. (%)c 1 (12.5%) 15 (21.1%) 1.00
Maternal history of atopy – no. (%)c 6 (75.0%) 43 (60.6%) 0.70
1st degree relative history of asthma/wheezing – no. (%)c 1 (12.5%) 25 (35.2%) 0.26
1st degree relative history atopy – no. (%)c 5 (62.5%) 49 (69.0%) 0.70
2nd degree relative history of asthma/wheezing – no. (%)c 3 (37.5%) 20 (28.2%) 0.69
2nd degree relative history atopy – no. (%)c 4 (50.0%) 35 (49.3%) 1.00
a

Fisher’s exact test or t-test

b

Spring = March, April, May; Summer = June, July, August; Fall = September, October, November; Winter = December, January, February

c

2 adopted children were removed before analysis.